Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.

G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...

This is an audio transcript of The Economics Show podcast episode: ‘Is AI (finally) making us more productive? With John Burn-Murdoch and Sarah O’Connor’ Soumaya Keynes I have read a lot of science ...

Daimler Truck Holding AG ( DTRUY) Q4 2025 Earnings Call March 12, 2026 4:00 AM EDT Good morning, everyone, and welcome to the 2025 Annual Results Conference of Daimler Truck. Thank you for joining us.

Discover what a matching strategy in finance entails and how investors use it to choose investments whose payouts align with future liabilities and planned expenses.

The Kochi-Muziris Biennale showcases how major international exhibitions can transcend traditional displays of art, transforming ordinary spaces into vibrant hubs of reflection, experimentation, ...

For over 40 years, the U.S. Forest Service has been monitoring high-altitude mountain lakes in Colorado to track the environmental impacts of human-caused pollutants and climate changes in delicate ...

A comparative evaluation indicates that climate anomalies over the past three years have been particularly severe. The rise in temperatures in certain regions, alongside unprecedented climate ...